• Loss of Stat3 in hematopoietic cells enhances JAK2-V617F driven thrombopoiesis and negatively impacts survival in mouse models.
Introduction
Myeloproliferative neoplasms (MPN) are characterized by aberrant proliferation of the erythroid, megakaryocytic, or myeloid lineages. MPN are subdivided into three disease entities: polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis. The acquired JAK2-V617F somatic mutation is present in the majority of patients with MPN and present in the different disease entities. [1] [2] [3] [4] Downstream of constitutively active JAK2-V617F, signal transducer and activator of transcription (Stat) proteins are phosphorylated, leading to the translocation of Stat protein dimers to the nucleus where they bind to cognate elements on the promoters of responsive genes. Stat5
is essential in the pathogenesis of MPN and deletion of Stat5 in JAK2-V617F transgenic mouse models abrogated the disease phenotypes. 5, 6 Activation of Stat1 constrains erythroid differentiation in MPN patients, 7 and loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F driven mouse model of MPN. 8 In contrast, the impact of Stat3 in JAK2-V617F driven MPN is less well understood. Stat3 was shown to play a role in hematopoiesis in the context of hyperactive gp130 signaling. 9, 10 While overexpression of a dominant negative form of Stat3 did not affect the baseline number of megakaryocytes and platelets, the rate of platelet recovery following 5-fluorouracil treatment was delayed. 11 Depending on the cellular context, Stat3 can act as a tumor suppressor or as an oncogene. A constitutive active version of Stat3 suppressed transformation of mouse embryonic fibroblasts deficient for p53, but expression of the activated Stat3 in bone marrow cells induced a highly aggressive T cell leukemia in mice. 12 There is also interest in Stat3 as a potential drug target in chronic myeloid leukemia. 13 Here, we studied the role of Stat3 in a mouse model of JAK2-V617F positive MPN.
JAK2-V617F transgenic mice were crossed with a conditional knockout of Stat3, 14 and bone marrow cells from double mutant mice were transplanted into lethally irradiated recipients. This allowed us to study the role of Stat3 in JAK2-V617F driven MPN.
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Methods

Transgenic mice
Mice carrying a floxed conditional knockout allele of Stat3 fl/fl , kindly provided by Valeria Poli , University of Torino, Italy, 14 were crossed with the SclCre ER mice, 15 and conditional transgenic mice expressing the human JAK2-V617F. 16 All strains were bred on the C57BL/6N background for more than 10 generations. Bone marrow transplantations were performed with 2x10 6 17 Cre expression in transplanted MxCre mice was induced by intraperitoneal injection of 300µg polyinosine-polycytosine (pIpC) 3 times every second day. All experiments were done in strict adherence to Swiss laws for animal welfare and approved by the Swiss Cantonal Veterinary Office of Basel-Stadt.
Blood and tissue analyses
Blood was collected into EDTA-coated microtainers (Becton, Dickinson and Company, USA) by tail vein sampling technique prior the start of dosing and by cardiac puncture as a part of the take-down procedure. Complete blood counts were determined on the ADVIA 120 Hematology Analyzer using Multispecies Software (Bayer, Leverkusen, Germany). Bone marrow (sternum and femur), spleen, liver and intestines for histopathological analysis were fixed in 4% phosphate buffered formalin and then embedded in paraffin. Formalin-fixed, paraffin-embedded tissue sections were stained with hematoxylin-eosin (H&E) and Gömöri (analysis of the amount and distribution of reticulin fibers). 
Flow cytometry and phosphoflow analysis
Hematopoietic progenitor assays
Colony forming unit megakaryocyte (CFU-MK) colonies were grown in duplicate chamber slides using a collagen-based medium (MegaCult-C, Stemcell Technologies, Vancouver, BC) containing 50 ng/mL rmIL-11, 10 ng/mL rmIL-3, 20 ng/mL rmIL-6 and 50 ng/mL rhTpo (PeproTech). Bone marrow or spleen cells (1x10 5 ) were plated per one double chamber slide and cultured at 37ºC with 5% CO 2 and 95% humidity for 8 days.
Then the slides were fixed, stained and scored according the manufacturer's protocol. Figure S3 ). The number of CFU-G colonies was increased in the bone marrow from SclCre;V617F mice and deletion of Stat3 had no effect on these numbers ( Figure 3I ).
We further examined the hematopoietic progenitor compartment (Figure 4) showed only a trend towards higher expression levels. We further analyzed expression of Stat1 and the Stat1 target genes Usp18 and Ifi27l2α ( Figure 6B ). Stat1 and Usp18 showed a trend towards lower expression, while no differences in Stat3 deletion efficiency were noted (Supplementary Figure S4) . These data are consistent with a less pronounced phosphorylation of Stat1 in CD41+ cells compared to total bone marrow ( Figure 5A ). In agreement with a previous study, 26 we also found a decrease of Socs3 
Phosphorylation of Stat1 was increased in BaF3 cells transduced with mouse Jak2-
V617F and the same trend was also seen with the human JAK2-V617F (Supplementary Figure S5C) . Altogether, these data suggest that signaling in the absence of Stat3 favors Stat1-driven gene expression, in particular when JAK2-V617F is co-expressed.
Finally, we tested the Stat3 inhibitor S3I-201 (NSC74859), an SH2 domain analogue, which prevents dimerization and selectively inhibits Stat3 DNA-binding activity. 18 Similar to the Stat3 deficient mice, the S3I-201 treated mice showed a trend towards increasing the platelet counts compared to vehicle when Stat1 was present, but this increase in platelet count was abolished in SclCre;V617F;Stat1 -/-mice ( Figure 7A ).
Spleen weight also showed dependence on the Stat1 genotype ( Figure 7B ). In addition, increase in CD41+ cells was found in the bone marrow of SclCre;V617F;Stat1 +/+ mice upon S3I-201 inhibitor treatment, whereas a slight decrease in CD41+ cells was noted in
SclCre;V617F;Stat1 -/-mice ( Figure 7C ). Overall, these findings suggest that the effect of Stat3 deletion may in part depend on Stat1 activity.
Discussion
We Tpo and Mpl signaling is primarily dependent on Stat5 activation and conditional Stat5 knockout normalized blood counts in JAK2-V617F driven models of MPN. 5, 6 Furthermore, Stat1 promotes megakaryopoiesis downstream of Gata1, 20 and deletion of Stat1 in the presence of JAK2-V617F reduced megakaryopoiesis and favored erythropoiesis in a mouse model of MPN. 8 We therefore hypothesized that the increased platelet counts in Stat3 deleted JAK2-V617F mice could be due to compensatory increase The JAK2-V617F copy number was retained upon Scl driven expression of the Cre recombinase, whereas repeated pIpC injections in MxCre mice decreased the number of JAK2-V617F copies leading to lower JAK2-V617F/Jak2 ratio and the occurrence of an ET-like phenotype, as previously reported. 16, 24 Acute enterocolitis resembling Crohn's disease with neutrophil infiltrates was first Tie2Cre;Stat3fl/fl mice. 27, 28 Using SclCre and MxCre bone marrow transplantation models we did not observe changes in neutrophil blood counts in Stat3 deficient mice on WT Jak2 background and deletion of Stat3 in JAK2-V617F transgenic mice in contrast even normalized the neutrophil counts. An important difference between our study and the previous reports is that the Stat3 knockout, due to bone marrow transplantation in our study, was limited to hematopoietic cells only, whereas in the two previous studies Stat3 was also deleted in non-hematopoietic cells. Thus, the differences in granulopoiesis may be due to presence or absence of Stat3 deletion in non-hematopoietic cells.
In conclusion, deletion of Stat3 in hematopoietic cells enhanced JAK2-V617F driven thrombocytosis potentially due to the increase in Stat1 expression and activation.
Targeting Stat3 in hematopoietic tissue reduced survival in MPN mouse models. 
